Skip to main content
. 2020 Aug 28;10:1738. doi: 10.3389/fonc.2020.01738

TABLE 3.

The univariate analysis of factors associated with PFS and OS in overall included patients.

Variables N Progression-free survival
Overall survival
HR 95% CI P HR 95% CI P
Age 0.563 0.418
<50 year 196 1 1
≥50 year 60 1.361 0.479–3.863 1.774 0.443–7.099
BMI 0.056 0.283
<24 kg/m2 164 1 1
≥24 kg/m2 92 2.567 0.977–6.747 2.062 0.550–7.731
Comorbidities 0.196 0.019
0 213 1 1
1 34 1.005 0.227–4.456 1.177 0.141–9.805
≥2 9 3.904 0.878–17.361 10.438 2.013–54.113
FIGO stage 0.406 0.577
IA1 with LVSI + IA2 21 1 1
IB1 235 23.102 0.014–38018.254 22.675 3.9 × 10–4–1318638.17
Histology 0.830 0.689
SCC 204 1 1
Non-SCC 52 0.873 0.250–3.040 0.653 0.081–5.250
Tumor grade 0.900 0.705
G1 133 1 1
G2 66 1.297 0.424–3.967 1.790 0.357–8.983
G3 57 1.133 0.341–3.767 1.846 0.367–9.286
Adjuvant treatment 0.224 0.137
No 155 1 1
Yes 101 1.807 0.697–4.684 2.879 0.715–11.593
Positive resection margin 0.858 0.896
No 255 1 1
Yes 1 0.049 2.7 × 10–12–9.1 × 1012 0.049 1.3 × 10–21–1.9 × 1018
Parametrial involvement 0.161 0.819
No 250 1 1
Yes 6 4.271 0.560–32.599 0.049 2.000–8.605 × 10–9
Lymph node metastasis 0.212 0.878
No 232 1 1
Yes 24 2.211 0.635–7.698 1.176 0.147–9.147
Cervical stromal invasion depth 0.144 0.489
<1/3 152 1 1
≥1/3, <2/3 81 2.425 0.841–6.990 1.284 0.287–5.740
≥2/3 23 3.314 0.829–13.254 2.807 0.512–15.387
Tumor mass size 0.017 0.495
≤2 cm 175 1 1
>2 cm 81 3.259 1.240–8.562 1.584 0.422–5.941
Operation approach 0.144 0.780
ARH 84 1 1
LRH 172 0.493 0.187–1.296 0.816 0.196–3.403

ARH, abdominal radical hysterectomy; LRH, laparoscopic radical hysterectomy; BMI, body mass index; FIGO, International Federation of Gynecology and Obstetrics; SCC, squamous-cell carcinoma.